211 related articles for article (PubMed ID: 24837771)
1. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M
Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771
[TBL] [Abstract][Full Text] [Related]
2. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
Pittman PR; Fisher D; Quinn X; Schmader T; Barrera-Oro JG
Vaccine; 2013 Oct; 31(44):5009-14. PubMed ID: 24026013
[TBL] [Abstract][Full Text] [Related]
3. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
Rynkiewicz D; Rathkopf M; Sim I; Waytes AT; Hopkins RJ; Giri L; DeMuria D; Ransom J; Quinn J; Nabors GS; Nielsen CJ
Vaccine; 2011 Aug; 29(37):6313-20. PubMed ID: 21624418
[TBL] [Abstract][Full Text] [Related]
4. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
[TBL] [Abstract][Full Text] [Related]
5. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
Dumas EK; Garman L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Choudhari S; Picking WD; James JA; Farris AD
Vaccine; 2017 Jun; 35(26):3416-3422. PubMed ID: 28504191
[TBL] [Abstract][Full Text] [Related]
6. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.
Pittman PR; Norris SL; Barrera Oro JG; Bedwell D; Cannon TL; McKee KT
Vaccine; 2006 Apr; 24(17):3654-60. PubMed ID: 16497418
[TBL] [Abstract][Full Text] [Related]
7. Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.
Quinn CP; Sabourin CL; Schiffer JM; Niemuth NA; Semenova VA; Li H; Rudge TL; Brys AM; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Parker SD; Babcock J; Keitel W; Poland GA; Keyserling HL; El Sahly H; Jacobson RM; Marano N; Plikaytis BD; Wright JG
Clin Vaccine Immunol; 2016 Apr; 23(4):326-38. PubMed ID: 26865594
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
[TBL] [Abstract][Full Text] [Related]
10. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.
Clement KH; Rudge TL; Mayfield HJ; Carlton LA; Hester A; Niemuth NA; Sabourin CL; Brys AM; Quinn CP
Clin Vaccine Immunol; 2010 Nov; 17(11):1753-62. PubMed ID: 20739500
[TBL] [Abstract][Full Text] [Related]
12. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
Wui SR; Han JE; Kim YH; Rhie GE; Lee NG
Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578
[TBL] [Abstract][Full Text] [Related]
13. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
Gorse GJ; Keitel W; Keyserling H; Taylor DN; Lock M; Alves K; Kenner J; Deans L; Gurwith M
Vaccine; 2006 Aug; 24(33-34):5950-9. PubMed ID: 16797805
[TBL] [Abstract][Full Text] [Related]
15. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.
Schiffer JM; Chen L; Dalton S; Niemuth NA; Sabourin CL; Quinn CP
Vaccine; 2015 Jul; 33(31):3709-16. PubMed ID: 26072016
[TBL] [Abstract][Full Text] [Related]
16. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.
Semenova VA; Schmidt DS; Taylor TH; Li H; Steward-Clark E; Soroka SD; Ballard MM; Quinn CP
Vaccine; 2007 Feb; 25(10):1780-8. PubMed ID: 17229495
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.
Chen L; Schiffer JM; Dalton S; Sabourin CL; Niemuth NA; Plikaytis BD; Quinn CP
Clin Vaccine Immunol; 2014 Nov; 21(11):1512-20. PubMed ID: 25185577
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel.
Singer DE; Schneerson R; Bautista CT; Rubertone MV; Robbins JB; Taylor DN
Vaccine; 2008 Feb; 26(7):869-73. PubMed ID: 18206278
[TBL] [Abstract][Full Text] [Related]
19. Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.
Pittman PR; Leitman SF; Oro JG; Norris SL; Marano NM; Ranadive MV; Sink BS; McKee KT
Clin Diagn Lab Immunol; 2005 Jun; 12(6):713-21. PubMed ID: 15939745
[TBL] [Abstract][Full Text] [Related]
20. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
